Joseph J. Frank's Insider Trades & SAST Disclosures
Joseph J. Frank's most recent trade in Old Republic International Corp. was a trade of 2,440 Common Stock done at an average price of $36.6 . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph J. Frank.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.59 per share. | 14 Mar 2025 | 2,440 | 43,569 (0%) | 0% | 36.6 | 89,280 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 43,086 | 43,086 | - | - | 2025 Employee Stock Option | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 8,263 | 8,263 | - | - | 2025 Restricted Stock Unit | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 3,007 | 46,891 (0%) | 0% | - | Common Stock | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 3,007 | 6,025 | - | - | 2024 Restricted Stock Unit | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.73 per share. | 06 Mar 2025 | 882 | 46,009 (0%) | 0% | 37.7 | 33,278 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.98 per share. | 03 Mar 2025 | 10,000 | 53,884 (0%) | 0% | 21.0 | 209,800 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 0 | - | - | 2018 Employee Stock Option | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.51 per share. | 03 Mar 2025 | 6,896 | 46,988 (0%) | 0% | 38.5 | 265,565 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Sale of securities on an exchange or to another person at price $ 38.84 per share. | 03 Mar 2025 | 3,094 | 43,894 (0%) | 0% | 38.8 | 120,171 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Sale of securities on an exchange or to another person at price $ 38.80 per share. | 03 Mar 2025 | 10 | 43,884 (0%) | 0% | 38.8 | 388 | Common Stock |
| Greenwich LifeSciences Inc | Frank Daugherty Joseph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 104,890 | 209,780 | - | - | Stock Options | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.30 per share. | 24 May 2024 | 2,951 | 43,884 (0%) | 0% | 31.3 | 92,366 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.13 per share. | 15 Mar 2024 | 2,523 | 46,835 (0%) | 0% | 29.1 | 73,495 | Common Stock |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 60,000 | 60,000 | - | - | 2024 Employee Stock Option | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 9,032 | 9,032 | - | - | 2024 Restricted Stock Unit | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 May 2023 | 1,952 | 49,358 (0%) | 0% | 0 | Common Stock | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 70,000 | 70,000 | - | - | 2023 Employee Stock Option | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 25,000 | 51,310 (0%) | 0% | 0 | Common Stock | |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,890 | 104,890 | - | - | Stock Options | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 May 2022 | 441 | 26,310 (0%) | 0% | 0 | Common Stock | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 60,000 | 60,000 | - | - | 2022 Employee Stock Option | |
| Old Republic International... | Frank Joseph Sodaro | Sr. VP. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 20,000 | 26,751 (0%) | 0% | 0 | Common Stock | |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 16.25 per share. | 25 Apr 2022 | 1,000 | 90,121 | - | 16.3 | 16,250 | Common Stock |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 89,121 | - | 20.0 | 19,990 | Common Stock |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 26.99 per share. | 14 Dec 2021 | 1,111 | 88,121 | - | 27.0 | 29,983 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 89.50 per share. | 18 Jun 2021 | 2 | 1,110 (0%) | 0% | 89.5 | 179 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 71.50 per share. | 18 Mar 2021 | 2 | 1,108 (0%) | 0% | 71.5 | 143 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.45 per share. | 10 Mar 2021 | 134 | 1,106 (0%) | 0% | 66.4 | 8,904 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.76 per share. | 10 Feb 2021 | 155 | 1,240 (0%) | 0% | 68.8 | 10,658 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.78 per share. | 11 Jan 2021 | 154 | 1,395 (0%) | 0% | 70.8 | 10,900 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 99.00 per share. | 16 Dec 2020 | 2 | 1,548 (0%) | 0% | 99 | 198 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.34 per share. | 10 Dec 2020 | 189 | 1,545 (0%) | 0% | 72.3 | 13,672 | Common Stock |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 23 Nov 2020 | 1,000 | 87,010 | - | 5.1 | 5,100 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.54 per share. | 10 Nov 2020 | 187 | 1,734 (0%) | 0% | 64.5 | 12,069 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.09 per share. | 12 Oct 2020 | 189 | 1,921 (0%) | 0% | 64.1 | 12,113 | Common Stock |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 1,739 | 86,010 | - | 5.7 | 9,999 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 22 Sep 2020 | 1,629 | 2,110 (0%) | 0% | 61 | 99,369 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 69.00 per share. | 16 Sep 2020 | 5 | 3,736 (0%) | 0% | 69 | 345 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 68.33 per share. | 16 Sep 2020 | 3 | 3,739 (0%) | 0% | 68.3 | 205 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.17 per share. | 10 Sep 2020 | 187 | 3,730 (0%) | 0% | 60.2 | 11,252 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.56 per share. | 10 Aug 2020 | 188 | 3,917 (0%) | 0% | 61.6 | 11,573 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.35 per share. | 09 Jul 2020 | 187 | 4,105 (0%) | 0% | 56.3 | 10,537 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 62.71 per share. | 16 Jun 2020 | 7 | 4,292 (0%) | 0% | 62.7 | 439 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 60.50 per share. | 16 Jun 2020 | 2 | 4,285 (0%) | 0% | 60.5 | 121 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 09 Jun 2020 | 187 | 4,283 (0%) | 0% | 59.8 | 11,175 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.33 per share. | 11 May 2020 | 188 | 4,470 (0%) | 0% | 57.3 | 10,778 | Common Stock |
| SS&C Technologies Holdings... | Joseph J. Frank | SVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.51 per share. | 09 Apr 2020 | 187 | 4,658 (0%) | 0% | 49.5 | 9,258 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges